Original Research
Published on 28 Mar 2023
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2023.1138416
- 4,964 views
- 6 citations